(Q37531863)

20 August 2017

1 reference

title

Diagnosis and treatment of melanoma brain metastasis: a literature review (English)

1 reference

20 August 2017

0 references

1 reference

Andrew E Sloan

1

1 reference

20 August 2017

Charles J Nock

series ordinal

2

1 reference

20 August 2017

Douglas B Einstein

series ordinal

3

1 reference

20 August 2017

language of work or name

1 reference

1 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

16

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

248-255

1 reference

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

The current causes of death in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Metastatic melanoma in brain. Rapid treatment or large dose fractions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Central nervous system involvement in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Solitary cerebral metastasis from melanoma: value of the 'en bloc' resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Chemotherapy for metastatic melanoma: time for a change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Determinants of outcome in melanoma patients with cerebral metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Treatment of melanoma metastases in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Cerebral metastases from malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

A randomized trial of surgery in the treatment of single metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Surgical treatment of multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Gamma Knife radiosurgery for numerous brain metastases: is this a safe treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Management of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Neoplastic meningitis-related encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

A phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600307

10.1177/107327480901600307

21 January 2018

Identifiers

DOI

0 references

1 reference